Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.06% Nasdaq Down 0.77%
Streaming
Ticker Tape: On

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
152.60 Down 3.50(2.24%) 2:55PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:156.10
Open:155.97
Bid:152.70 x 200
Ask:152.87 x 100
1y Target Est:190.95
Beta:0.51
Next Earnings Date:24-Apr-14ALXN Earnings announcement
Day's Range:150.23 - 156.98
52wk Range:87.01 - 185.43
Volume:872,653
Avg Vol (3m):1,940,260
Market Cap:30.19B
P/E (ttm):120.16
EPS (ttm):1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 2.24%30.19B
AMGNDown 5.99%84.67B
BAXDown 0.24%39.22B

Key Statistics

Forward P/E (1 yr):28.38
P/S (ttm):19.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.49
Quarterly EPS Est (Mar-14) :1.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback